US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Jade Biosciences

21.36

+0.52002.50%

Post-market: 21.360.00000.00%19:30 EDT

Volume:837.04K

Turnover:17.70M

Market Cap:1.36B

PE:-9.12

High:21.45

Open:20.65

Low:20.35

Close:20.84

52wk High:28.00

52wk Low:6.91

Shares:63.60M

Float Shares:47.12M

Volume Ratio:1.86

T/O Rate:1.78%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3433

EPS(LYR):-3.1931

ROE:-89.18%

ROA:-33.59%

PB:0.47

PE(LYR):-6.69

Loading ...

Overview Company News Filings

BRIEF-Jade Biosciences Inc - May Offer And Sell Up To $600 Million Of Securities - SEC Filing

Jade Biosciences Inc - Registration Statement Covers Resale of up to 39,542,339 Shares of Common Stock by the Selling Stockholders - SEC Filing

THOMSON REUTERS

Jade Biosciences Inc - May Offer and Sell up to $600 Mln of Securities - SEC Filing

THOMSON REUTERS

Jade Biosciences Q1 EPS $(0.57) Misses $(0.51) Estimate

Benzinga Earnings

Jade Biosciences Q1 net loss widens to $40.4 million; R&D expenses rise to $36.1 million

BRIEF-Jade Biosciences, Inc Q1 Cash & Investments USD 311.3 Million

Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update

Jade Biosciences Reshapes Clinical Leadership As Valuation Debate Persists

Simply Wall St.

A Look At Jade Biosciences (JBIO) Valuation After Its Recent Share Price Surge

Simply Wall St.

Jade Biosciences Is Maintained at Buy by HC Wainwright & Co.

Jade Biosciences price target raised to $45 from $35 at H.C. Wainwright

Jade Biosciences, Inc. : H.c. Wainwright Raises Target Price to $45 From $35

THOMSON REUTERS

Jade Biosciences grants CMO Conner stock options for 500,000 shares at $25.38

Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Analysts Conflicted on These Healthcare Names: Jade Biosciences (JBIO), Elevance Health (ELV) and Regeneron (REGN)

Jade Biosciences appoints Edward Conner as chief medical officer

Press Release: Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer

We're Hopeful That Jade Biosciences (NASDAQ:JBIO) Will Use Its Cash Wisely

Simply Wall St.

Jade Biosciences announces annual shareholder meeting

Jade Biosciences Inc expected to post a loss of 48 cents a share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/JBIO/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","market":"US","secType":"STK","nameCN":"Jade Biosciences","latestPrice":21.36,"timestamp":1788206400000,"preClose":20.84,"halted":0,"volume":837036,"hourTrading":{"tag":"盘后","latestPrice":21.36,"preClose":21.36,"latestTime":"19:30 EDT","volume":41412,"amount":884542.925876,"timestamp":1788219003160,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.024952015355086354,"floatShares":47122000,"shares":63597387,"eps":-2.343303,"marketStatus":"Closed","change":0.52,"latestTime":"08-31 16:00:00 EDT","open":20.65,"high":21.45,"low":20.35,"amount":17695091.70648,"amplitude":0.052783,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.343303,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":5,"adr":0,"listingDate":1625025600000,"exchange":"NASDAQ","adjPreClose":20.84,"preHourTrading":{"tag":"盘前","latestPrice":20.01,"preClose":20.84,"latestTime":"09:09 EDT","volume":6,"amount":122.43,"timestamp":1788181761820,"change":-0.83,"changeRate":-0.039827,"amplitude":0.03071},"postHourTrading":{"tag":"盘后","latestPrice":21.36,"preClose":21.36,"latestTime":"19:30 EDT","volume":41412,"amount":884542.925876,"timestamp":1788219003160,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.855385,"impliedVol":0.915,"impliedVolPercentile":0.7052},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JBIO\",,,,,undefined,":{"symbol":"JBIO","floatShares":47122000,"roa":"-33.59%","roe":"-89.18%","lyrEps":-3.193116,"volumeRatio":1.855385,"shares":63597387,"dividePrice":0,"high":21.45,"amplitude":0.052783,"preClose":20.84,"low":20.35,"week52Low":6.91,"pbRate":"0.47","week52High":28,"institutionHeld":0,"latestPrice":21.36,"eps":-2.343303,"divideRate":0,"volume":837036,"delay":0,"ttmEps":-2.343303,"open":20.65,"prevYearClose":15.43,"prevWeekClose":20.84,"prevMonthClose":19.75,"prevQuarterClose":22.22,"fiveDayClose":21.33,"twentyDayClose":19.15,"sixtyDayClose":17.74,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.15429122468659595},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-10","symbol":"JBIO","fiscalQuarterEnding":"2026/06","expectedEps":-0.66,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786334400000,"reportTimeType":"pre","actualEps":-0.76},{"market":"US","date":"2026-05-07","symbol":"JBIO","fiscalQuarterEnding":"2026/03","expectedEps":-0.52,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"post","actualEps":-0.57},{"market":"US","date":"2026-03-06","symbol":"JBIO","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772773200000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2025-11-13","symbol":"JBIO","fiscalQuarterEnding":"2025/09","expectedEps":-0.57,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.48},{"market":"US","date":"2025-08-13","symbol":"JBIO","fiscalQuarterEnding":"2025/06","expectedEps":-0.43,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.86}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JBIO\",market:\"US\",,,undefined,":[{"executeDate":"2025-04-29","recordDate":"2025-04-25","paymentDate":"2025-04-28","value":2.4,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JBIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5455,"buy":0.4545,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5455,"analysts":11,"updateTime":1781668800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JBIO","date":"2026-08-28","current":-9.115338,"percent":0.203077,"low":-10.392766,"twenty":-8.844495,"median":-6.229853,"eighty":-2.840774,"high":-2.319279,"avg":-5.847874,"sd":2.681563,"marketCap":1353988369},"quantilePoints":[{"date":"2025-05-16","current":-2.4743,"twenty":-2.881556,"median":-2.868851,"eighty":-2.514424,"marketCap":232480279},{"date":"2025-05-23","current":-2.511409,"twenty":-2.870857,"median":-2.517932,"eighty":-2.47965,"marketCap":235966978},{"date":"2025-05-30","current":-2.432499,"twenty":-2.695315,"median":-2.507901,"eighty":-2.466944,"marketCap":228552715},{"date":"2025-06-06","current":-2.363881,"twenty":-2.548988,"median":-2.487393,"eighty":-2.464507,"marketCap":222105530},{"date":"2025-06-13","current":-2.381035,"twenty":-2.548988,"median":-2.48419,"eighty":-2.428382,"marketCap":223717326},{"date":"2025-06-20","current":-3.228464,"twenty":-2.618978,"median":-2.48419,"eighty":-2.41603,"marketCap":303340063},{"date":"2025-06-27","current":-3.17357,"twenty":-2.886906,"median":-2.487393,"eighty":-2.426323,"marketCap":298182315},{"date":"2025-07-03","current":-3.822008,"twenty":-3.217485,"median":-2.511409,"eighty":-2.437181,"marketCap":359108215},{"date":"2025-07-11","current":-3.609293,"twenty":-3.553713,"median":-2.554094,"eighty":-2.45809,"marketCap":339121941},{"date":"2025-07-18","current":-3.262773,"twenty":-3.420594,"median":-2.844205,"eighty":-2.467494,"marketCap":306563656},{"date":"2025-07-25","current":-2.857929,"twenty":-3.391775,"median":-2.873866,"eighty":-2.470924,"marketCap":268525263},{"date":"2025-08-01","current":-2.466808,"twenty":-3.382854,"median":-2.844205,"eighty":-2.467494,"marketCap":231776307},{"date":"2025-08-08","current":-2.511409,"twenty":-3.347859,"median":-2.705254,"eighty":-2.467494,"marketCap":235966978},{"date":"2025-08-15","current":-2.350869,"twenty":-3.260028,"median":-2.645214,"eighty":-2.467494,"marketCap":220882962},{"date":"2025-08-22","current":-2.56269,"twenty":-3.244933,"median":-2.581542,"eighty":-2.467494,"marketCap":240785267},{"date":"2025-08-29","current":-2.805764,"twenty":-3.217485,"median":-2.645214,"eighty":-2.470924,"marketCap":263623978},{"date":"2025-09-05","current":-2.70159,"twenty":-3.17357,"median":-2.64603,"eighty":-2.473669,"marketCap":253835959},{"date":"2025-09-12","current":-2.694645,"twenty":-3.152985,"median":-2.64603,"eighty":-2.4743,"marketCap":253183424},{"date":"2025-09-19","current":-2.677282,"twenty":-3.087798,"median":-2.64603,"eighty":-2.473669,"marketCap":251552088},{"date":"2025-09-26","current":-2.798819,"twenty":-3.080936,"median":-2.64603,"eighty":-2.4743,"marketCap":262971443},{"date":"2025-10-03","current":-2.892576,"twenty":-3.080936,"median":-2.67381,"eighty":-2.479351,"marketCap":271780660},{"date":"2025-10-10","current":-3.264131,"twenty":-3.152985,"median":-2.690514,"eighty":-2.480987,"marketCap":306691262},{"date":"2025-10-17","current":-3.397822,"twenty":-3.16343,"median":-2.70159,"eighty":-2.487393,"marketCap":319252553},{"date":"2025-10-24","current":-3.448173,"twenty":-3.228464,"median":-2.743259,"eighty":-2.487393,"marketCap":323983428},{"date":"2025-10-31","current":-3.420393,"twenty":-3.264131,"median":-2.760622,"eighty":-2.487393,"marketCap":321373290},{"date":"2025-11-07","current":-3.10787,"twenty":-3.295384,"median":-2.802291,"eighty":-2.501116,"marketCap":292009233},{"date":"2025-11-14","current":-3.361361,"twenty":-3.350943,"median":-2.840774,"eighty":-2.504393,"marketCap":315826746},{"date":"2025-11-21","current":-5.620897,"twenty":-3.393147,"median":-2.85789,"eighty":-2.511409,"marketCap":528128273},{"date":"2025-11-28","current":-6.276995,"twenty":-3.403031,"median":-2.873866,"eighty":-2.511409,"marketCap":589773908},{"date":"2025-12-05","current":-6.071353,"twenty":-3.439839,"median":-2.892576,"eighty":-2.514154,"marketCap":570452142},{"date":"2025-12-12","current":-7.266038,"twenty":-3.474564,"median":-2.963052,"eighty":-2.522532,"marketCap":682702402},{"date":"2025-12-19","current":-8.108193,"twenty":-3.595569,"median":-2.993278,"eighty":-2.527742,"marketCap":761829634},{"date":"2025-12-26","current":-8.093505,"twenty":-3.607234,"median":-3.022611,"eighty":-2.532681,"marketCap":760449508},{"date":"2026-01-02","current":-7.554917,"twenty":-3.822008,"median":-3.080936,"eighty":-2.536797,"marketCap":709844883},{"date":"2026-01-09","current":-6.487534,"twenty":-5.801079,"median":-3.116551,"eighty":-2.545612,"marketCap":609555716},{"date":"2026-01-16","current":-7.197491,"twenty":-6.02239,"median":-3.152985,"eighty":-2.555745,"marketCap":676261813},{"date":"2026-01-23","current":-8.333421,"twenty":-6.159485,"median":-3.153012,"eighty":-2.557134,"marketCap":782991569},{"date":"2026-01-30","current":-7.530436,"twenty":-6.394505,"median":-3.1685,"eighty":-2.564099,"marketCap":707544672},{"date":"2026-02-06","current":-7.045707,"twenty":-6.577625,"median":-3.177319,"eighty":-2.571103,"marketCap":662000509},{"date":"2026-02-13","current":-7.251349,"twenty":-6.621691,"median":-3.225463,"eighty":-2.577189,"marketCap":681322276},{"date":"2026-02-20","current":-7.124047,"twenty":-6.808238,"median":-3.251382,"eighty":-2.579625,"marketCap":669361182},{"date":"2026-02-27","current":-7.128943,"twenty":-6.986952,"median":-3.264131,"eighty":-2.583458,"marketCap":669821224},{"date":"2026-03-06","current":-6.795998,"twenty":-6.986952,"median":-3.314482,"eighty":-2.597415,"marketCap":638538365},{"date":"2026-03-13","current":-5.364757,"twenty":-6.933093,"median":-3.361361,"eighty":-2.602624,"marketCap":683523737},{"date":"2026-03-20","current":-5.449912,"twenty":-6.913508,"median":-3.389716,"eighty":-2.60436,"marketCap":694373320},{"date":"2026-03-27","current":-5.399593,"twenty":-6.874338,"median":-3.399558,"eighty":-2.630404,"marketCap":687962203},{"date":"2026-04-02","current":-6.200823,"twenty":-6.843002,"median":-3.403031,"eighty":-2.640126,"marketCap":790046917},{"date":"2026-04-10","current":-7.056243,"twenty":-6.843002,"median":-3.432606,"eighty":-2.644683,"marketCap":899035912},{"date":"2026-04-17","current":-8.46904,"twenty":-6.943865,"median":-3.47248,"eighty":-2.645867,"marketCap":1079040359},{"date":"2026-04-24","current":-9.757975,"twenty":-7.080959,"median":-3.477689,"eighty":-2.64603,"marketCap":1243263595},{"date":"2026-05-01","current":-9.451524,"twenty":-7.125026,"median":-3.585277,"eighty":-2.656356,"marketCap":1204218641},{"date":"2026-05-08","current":-9.381799,"twenty":-7.197491,"median":-3.600715,"eighty":-2.670835,"marketCap":1195335061},{"date":"2026-05-15","current":-9.189592,"twenty":-7.279748,"median":-3.609293,"eighty":-2.676588,"marketCap":1191053783},{"date":"2026-05-22","current":-8.934431,"twenty":-7.436993,"median":-3.822008,"eighty":-2.684564,"marketCap":1157982667},{"date":"2026-05-29","current":-7.936639,"twenty":-7.480494,"median":-5.132517,"eighty":-2.691341,"marketCap":1028659795},{"date":"2026-06-05","current":-6.756045,"twenty":-7.480494,"median":-5.23899,"eighty":-2.696728,"marketCap":875644182},{"date":"2026-06-12","current":-7.36451,"twenty":-7.480494,"median":-5.370563,"eighty":-2.700201,"marketCap":954506790},{"date":"2026-06-18","current":-7.726324,"twenty":-7.487348,"median":-5.393787,"eighty":-2.710604,"marketCap":1001401091},{"date":"2026-06-26","current":-9.988804,"twenty":-7.591639,"median":-5.407335,"eighty":-2.731778,"marketCap":1294638873},{"date":"2026-07-02","current":-9.988804,"twenty":-7.673406,"median":-5.426688,"eighty":-2.743259,"marketCap":1294638873},{"date":"2026-07-10","current":-10.295658,"twenty":-7.795377,"median":-5.444106,"eighty":-2.744648,"marketCap":1334409990},{"date":"2026-07-17","current":-9.379675,"twenty":-7.921008,"median":-5.585386,"eighty":-2.752288,"marketCap":1215690240},{"date":"2026-07-24","current":-8.985802,"twenty":-8.046029,"median":-5.655171,"eighty":-2.766178,"marketCap":1164640747},{"date":"2026-07-31","current":-9.159838,"twenty":-8.108193,"median":-5.875502,"eighty":-2.788402,"marketCap":1187197500},{"date":"2026-08-07","current":-10.18574,"twenty":-8.267967,"median":-5.948946,"eighty":-2.798819,"marketCap":1320163620},{"date":"2026-08-14","current":-9.881583,"twenty":-8.338317,"median":-6.086042,"eighty":-2.805764,"marketCap":1514253784},{"date":"2026-08-21","current":-8.810836,"twenty":-8.64582,"median":-6.164381,"eighty":-2.819654,"marketCap":1350172526},{"date":"2026-08-28","current":-8.835737,"twenty":-8.844495,"median":-6.229853,"eighty":-2.840774,"marketCap":1353988369}],"updateTime":1788233243549},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JBIO\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633103496","title":"BRIEF-Jade Biosciences Inc - May Offer And Sell Up To $600 Million Of Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633103496","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633103496?lang=en_us&edition=fundamental","pubTime":"2026-05-08 06:27","pubTimestamp":1778192858,"startTime":"0","endTime":"0","summary":"BRIEF-Jade Biosciences Inc - May Offer And Sell Up To $600 Million Of Securities - SEC FilingMay 7  - SEC Filing: JADE BIOSCIENCES INC - MAY OFFER AND SELL UP TO $600 MILLION OF SECURITIES - SEC FILINGJADE BIOSCIENCES INC - MAY OFFER AND SELL UP TO $200 MILLION COMMON STOCK UNDER SALES AGREEMENT WITH JEFFERIES - SEC FILINGSource text: [ID:n0001193125-26-212422]Further company coverage: JBIO.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K1MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633170901","title":"Jade Biosciences Inc - Registration Statement Covers Resale of up to 39,542,339 Shares of Common Stock  by the Selling Stockholders  - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633170901","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633170901?lang=en_us&edition=fundamental","pubTime":"2026-05-08 05:21","pubTimestamp":1778188898,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K1MN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633170548","title":"Jade Biosciences Inc - May Offer and Sell up to $600 Mln of Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2633170548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633170548?lang=en_us&edition=fundamental","pubTime":"2026-05-08 05:15","pubTimestamp":1778188553,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K1MK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","JBIO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633174738","title":"Jade Biosciences Q1 EPS $(0.57) Misses $(0.51) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633174738","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633174738?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:35","pubTimestamp":1778186138,"startTime":"0","endTime":"0","summary":"Jade Biosciences (NASDAQ:JBIO) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.51) by 11.76 percent. This is a 95.29 percent increase over losses of $(12.10) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52392153/jade-biosciences-q1-eps-0-57-misses-0-51-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Jade Biosciences Q1 EPS $(0.57) Misses $(0.51) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633637174","title":"Jade Biosciences Q1 net loss widens to $40.4 million; R&D expenses rise to $36.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633637174","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633637174?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:29","pubTimestamp":1778185782,"startTime":"0","endTime":"0","summary":"Jade Biosciences posted a Q1 net loss of $40.4 million, compared with a $38.2 million loss a year earlier.R&D expense climbed to $36.1 million from $20 million, while G&A costs rose to $7.4 million from $3.4 million.Cash, cash equivalents, investments totaled $311.3 million as of March 31, with runway expected into first-half 2028.Phase 2 trial of lead IgA nephropathy candidate JADE101 expected to start in Q2, with interim data expected in 2027; interim biomarker-rich Phase 1 data set for an oral presentation at the European Renal Association Congress.Phase 1 study of JADE201 in rheumatoid arthritis expected to begin in Q2 with interim data expected in 2027, while JADE301 first-in-human trial remains on track for first-half 2027.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDLbq1Hkw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BN0W2T93.GBP","BK4585","IE00B3QW5Z07.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","SG9999014013.SGD","NDAQ","JBIO","SG9999014005.SGD","LU0314104364.USD","BK4539","LU2095319765.USD","SG9999014039.USD","IE00BN0W2V16.EUR","BK4112","SG9999014021.USD","LU2210150020.SGD","BK4588","IE00BN0W2W23.USD","BK4139","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633179547","title":"BRIEF-Jade Biosciences, Inc Q1 Cash & Investments USD 311.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633179547","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633179547?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:05","pubTimestamp":1778184357,"startTime":"0","endTime":"0","summary":"BRIEF-Jade Biosciences, Inc Q1 Cash & Investments USD 311.3 Million\n\n\nMay 07 (Reuters) - Jade Biosciences, Inc Q1 net income USD -40.4 million vs. IBES estimate USD -32.5 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nPLXA86001:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","JBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633726311","title":"Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2633726311","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633726311?lang=en_us&edition=fundamental","pubTime":"2026-05-08 04:05","pubTimestamp":1778184300,"startTime":"0","endTime":"0","summary":"Interim biomarker-rich Phase 1 data for JADE101 to be featured in an oral session at the 63rd European Renal Association CongressPhase 2 trial of JADE101 in IgA nephropathy patients expected to begin ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/07/3290531/0/en/Jade-Biosciences-Reports-First-Quarter-2026-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","JBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632623219","title":"Jade Biosciences Reshapes Clinical Leadership As Valuation Debate Persists","url":"https://stock-news.laohu8.com/highlight/detail?id=2632623219","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632623219?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:49","pubTimestamp":1777672186,"startTime":"0","endTime":"0","summary":"Jade Biosciences (NasdaqCM: JBIO) appointed Edward R. Conner, M.D. as Chief Medical Officer.\nThe company elevated Andrew King, M.D., Ph.D. to President, Research & Development.\nThese leadership changes focus on clinical development, regulatory strategy, and R&D continuity for Jade's autoimmune pipeline.\n\nJade Biosciences, listed on NasdaqCM under the ticker JBIO, is focused on developing therapies for autoimmune conditions, an area that continues to attract capital and partnerships across...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jbio/jade-biosciences/news/jade-biosciences-reshapes-clinical-leadership-as-valuation-d","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jbio/jade-biosciences/news/jade-biosciences-reshapes-clinical-leadership-as-valuation-d","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","JBIO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630394343","title":"A Look At Jade Biosciences (JBIO) Valuation After Its Recent Share Price Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2630394343","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630394343?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:07","pubTimestamp":1777324054,"startTime":"0","endTime":"0","summary":"What Jade Biosciences’ Recent Move Means For Investors\n\nJade Biosciences (JBIO) has caught investor attention after a sharp share price move over the past month, prompting a closer look at how its current fundamentals and recent trading performance line up.\n\nSee our latest analysis for Jade Biosciences.\n\nAt a share price of US$24.98, Jade Biosciences has seen momentum build, with a 7 day share price return of 6.3%, a 30 day share price return of 86.6% and a year to date share price return of...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jbio/jade-biosciences/news/a-look-at-jade-biosciences-jbio-valuation-after-its-recent-s","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jbio/jade-biosciences/news/a-look-at-jade-biosciences-jbio-valuation-after-its-recent-s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630396620","title":"Jade Biosciences Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2630396620","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630396620?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:00","pubTimestamp":1777291200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/JBIO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 27, 2026 08:00 ET (12:00 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630367635","title":"Jade Biosciences price target raised to $45 from $35 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2630367635","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630367635?lang=en_us&edition=fundamental","pubTime":"2026-04-27 18:16","pubTimestamp":1777284993,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Jade Biosciences (JBIO) to $45 from $35 and keeps a Buy rating on the shares. The company is set ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jade-biosciences-price-target-raised-to-45-from-35-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jade-biosciences-price-target-raised-to-45-from-35-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630234362","title":"Jade Biosciences, Inc. : H.c. Wainwright Raises Target Price to $45 From $35","url":"https://stock-news.laohu8.com/highlight/detail?id=2630234362","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630234362?lang=en_us&edition=fundamental","pubTime":"2026-04-27 18:11","pubTimestamp":1777284683,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nAZN4SSX2S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","JBIO","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629833396","title":"Jade Biosciences grants CMO Conner stock options for 500,000 shares at $25.38","url":"https://stock-news.laohu8.com/highlight/detail?id=2629833396","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629833396?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:04","pubTimestamp":1776942288,"startTime":"0","endTime":"0","summary":"Jade Biosciences granted Edward R. Conner non-qualified stock options for 500,000 shares, effective April 22, 2026, tied to his appointment as chief medical officer.Options carry an exercise price of $25.38 per share.Vesting runs over four years, with 25% vesting at one year.Remaining shares vest in 36 equal monthly installments, subject to continued employment.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDLbVtPvk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","BK4139","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2T93.GBP","BK4539","LU2210150020.SGD","BK4588","SG9999014039.USD","JBIO","BK4112","IE00BKPKM429.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","LU2095319765.USD","BK4585","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00B64PRP62.GBP","NDAQ","IE00BN0W2W23.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629293838","title":"Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629293838","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629293838?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:00","pubTimestamp":1776942003,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nTUA2LJPFW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","JBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629884102","title":"Analysts Conflicted on These Healthcare Names: Jade Biosciences (JBIO), Elevance Health (ELV) and Regeneron (REGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629884102","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629884102?lang=en_us&edition=fundamental","pubTime":"2026-04-23 17:41","pubTimestamp":1776937299,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Jade Biosciences (JBIO), Elevance Health (ELV) and...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-jade-biosciences-jbio-elevance-health-elv-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-jade-biosciences-jbio-elevance-health-elv-and-regeneron-regn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2362541513.USD","LU2106854487.HKD","LU0251131958.USD","REGN","XBI","LU1506573853.SGD","LABU","LU1548497426.USD","LU0957791311.USD","LU0320765489.SGD","LU0823434740.USD","LU2430703095.HKD","LU0061474960.USD","LU1280957306.USD","BK4137","LU1023059063.AUD","LU0266013472.USD","LU2430703251.USD","LU0433182093.SGD","LU0557290698.USD","LU0985489474.SGD","SG9999004303.SGD","JBIO","LU0068578508.USD","XLV","LU0048573561.USD","LU1057294990.SGD","LU0345770993.USD","LU0320765992.SGD","LU0882574055.USD","LU0128526141.USD","LU0225283273.USD","LU2089984988.USD","LU0251142724.SGD","LU0878866978.SGD","LU0345770308.USD","LU2505996509.AUD","SG9999011175.SGD","LU2237957902.USD","LU2362541273.HKD","LU2592432038.USD","LU2362540622.SGD","BK4581","LU1201861249.SGD","LU2108987350.USD","BK4585","LU0130517989.USD","HCSG","ELV","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629045747","title":"Jade Biosciences appoints Edward Conner as chief medical officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2629045747","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629045747?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:54","pubTimestamp":1776858868,"startTime":"0","endTime":"0","summary":"Jade Biosciences (JBIO) announced the appointment of Edward Conner as chief medical officer, effective immediately. Conner joins Jade from Ardelyx ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jade-biosciences-appoints-edward-conner-as-chief-medical-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jade-biosciences-appoints-edward-conner-as-chief-medical-officer-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JBIO","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629010087","title":"Press Release: Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2629010087","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629010087?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:00","pubTimestamp":1776855600,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO and VANCOUVER, British Columbia, April 22, 2026  -- Jade Biosciences, Inc.  , a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced the appointment of Edward R. Conner, M.D., as Chief Medical Officer , effective today.Dr. Conner is an accomplished biopharmaceutical executive with extensive experience spanning clinical development, translational medicine, regulatory strategy and mechanism-based drug development, across early- to late-stage programs. As Chief Medical Officer, he will lead Jade's clinical and medical organization, overseeing development strategy and data generation to support the advancement of the Company's differentiated pipeline of potentially disease-modifying therapies for autoimmune diseases.Dr. Conner received his M.D. from the University of California, San Francisco. He completed his residency in internal medicine at the University of Michigan and a fellowship in clinical immunol","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","R","BK4022","BK4139","BK4539","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629105863","title":"We're Hopeful That Jade Biosciences (NASDAQ:JBIO) Will Use Its Cash Wisely","url":"https://stock-news.laohu8.com/highlight/detail?id=2629105863","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629105863?lang=en_us&edition=fundamental","pubTime":"2026-04-21 21:14","pubTimestamp":1776777270,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jbio/jade-biosciences/news/were-hopeful-that-jade-biosciences-nasdaqjbio-will-use-its-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-jbio/jade-biosciences/news/were-hopeful-that-jade-biosciences-nasdaqjbio-will-use-its-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NDX","MNQmain","BK4139","BK4539","IYW","JEPQ","TQQY","QQQJ","QQQ","QQQM","QID","QDTE","SQQQ","QYLG","QQQY","TQQQ","JBIO","QQQE",".IXIC","NVIW.SI","NQmain","PSQ","QLD","ONEQ","FTEC","QQQA","GPIQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628881784","title":"Jade Biosciences announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2628881784","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628881784?lang=en_us&edition=fundamental","pubTime":"2026-04-18 04:19","pubTimestamp":1776457194,"startTime":"0","endTime":"0","summary":"Vote set on election of two Class II directors, including Christopher Cain, Ph.D. and Tom Frohlich.Stockholders to consider amendment to articles of incorporation to add a jury-trial waiver for certain internal actions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jade Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 17, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDLb6KckQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JBIO","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628208439","title":"Jade Biosciences Inc  expected to post a loss of 48 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2628208439","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628208439?lang=en_us&edition=fundamental","pubTime":"2026-04-17 19:07","pubTimestamp":1776424025,"startTime":"0","endTime":"0","summary":"Jade Biosciences Inc  expected to post a loss of48cents a share - Earnings Preview Jade Biosciences Inc JBIO.OQ JBIO.O is expected to  show no change in quarterly revenue when it reports  results on A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nL8N4100ST:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","JBIO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":5,"totalSize":122,"code":"91000000","status":"200"}]}}